A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,983 shares of EDIT stock, worth $7,189. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,983
Previous 2,455 21.51%
Holding current value
$7,189
Previous $11,000 9.09%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$3.39 - $5.96 $1,789 - $3,146
528 Added 21.51%
2,983 $10,000
Q2 2024

Jul 30, 2024

SELL
$4.67 - $7.28 $1.46 Million - $2.27 Million
-312,319 Reduced 99.22%
2,455 $11,000
Q1 2024

May 01, 2024

BUY
$7.03 - $11.07 $821,125 - $1.29 Million
116,803 Added 59.0%
314,774 $2.34 Million
Q4 2023

Jan 24, 2024

SELL
$6.25 - $11.11 $1.11 Million - $1.97 Million
-177,556 Reduced 47.28%
197,971 $2.01 Million
Q3 2023

Oct 26, 2023

BUY
$6.92 - $9.31 $181,511 - $244,201
26,230 Added 7.51%
375,527 $2.93 Million
Q2 2023

Aug 10, 2023

BUY
$6.36 - $11.47 $199,831 - $360,387
31,420 Added 9.88%
349,297 $2.87 Million
Q1 2023

May 04, 2023

BUY
$7.03 - $11.53 $198,773 - $326,010
28,275 Added 9.76%
317,877 $2.3 Million
Q4 2022

Feb 09, 2023

SELL
$8.32 - $13.21 $525,299 - $834,039
-63,137 Reduced 17.9%
289,602 $2.57 Million
Q3 2022

Nov 10, 2022

BUY
$12.16 - $19.42 $560,332 - $894,873
46,080 Added 15.03%
352,739 $4.32 Million
Q2 2022

Jul 26, 2022

BUY
$9.99 - $21.35 $893,685 - $1.91 Million
89,458 Added 41.19%
306,659 $3.63 Million
Q1 2022

May 10, 2022

SELL
$14.08 - $27.63 $616,844 - $1.21 Million
-43,810 Reduced 16.78%
217,201 $4.13 Million
Q4 2021

Feb 08, 2022

BUY
$26.55 - $40.57 $1.49 Million - $2.27 Million
55,940 Added 27.28%
261,011 $6.93 Million
Q3 2021

Nov 15, 2021

BUY
$39.27 - $72.94 $1.51 Million - $2.8 Million
38,454 Added 23.08%
205,071 $8.42 Million
Q2 2021

Aug 11, 2021

BUY
$31.29 - $56.64 $877,402 - $1.59 Million
28,041 Added 20.24%
166,617 $9.44 Million
Q1 2021

May 13, 2021

BUY
$39.71 - $90.58 $2.49 Million - $5.68 Million
62,711 Added 82.66%
138,576 $5.82 Million
Q4 2020

Feb 10, 2021

BUY
$27.07 - $84.35 $681,433 - $2.12 Million
25,173 Added 49.66%
75,865 $5.32 Million
Q3 2020

Nov 12, 2020

BUY
$28.06 - $37.16 $446,743 - $591,624
15,921 Added 45.79%
50,692 $1.42 Million
Q2 2020

Aug 11, 2020

BUY
$18.5 - $34.34 $276,131 - $512,558
14,926 Added 75.21%
34,771 $1.03 Million
Q1 2020

May 12, 2020

BUY
$14.88 - $32.78 $32,230 - $71,001
2,166 Added 12.25%
19,845 $393,000
Q4 2019

Feb 12, 2020

BUY
$19.49 - $32.63 $47,146 - $78,931
2,419 Added 15.85%
17,679 $524,000
Q3 2019

Nov 12, 2019

BUY
$22.49 - $26.81 $343,197 - $409,120
15,260 New
15,260 $347,000

Others Institutions Holding EDIT

About Editas Medicine, Inc.


  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $166M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.